A Game-Changer in Liver Cancer Management: Atezolizumab-Bevacizumab Combination Extends Liver Cancer Patients’ Survival, Promises New Era in Treatment

With Atezolizumab-Bevacizumab combination median overall survival was 12 months In patients with good liver function, survival was 21 months A first-of-its-kind study in real world setting conducted in India by Asian Institute of Gastroenterology (AIG) and published in the Journal of Clinical and Experimental ....

Continue reading

CrowdStrike Announces Falcon Complete for Service Providers, Extending Elite Managed Detection and Response Services to Global Partner Network

MSSPs, MSPs, SIs, GSIs can now create and deliver new managed security services leveraging CrowdStrike’s industry-leading MDR and MXDR offerings CrowdStrike (NASDAQ: CRWD), today announced Falcon Complete for Service Providers, a new program that gives Managed Security Service ....

Continue reading